Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001465826-13-000004)

Filing Details

Accession Number:: 0001465826-13-000004
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-11-19 21:21:14
Reporting Period:: 2013-11-14

Filing Date:: 2013-11-19
Accepted Time:: 2013-11-19 21:21:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1053369	Elite Pharmaceuticals Inc	ELTP	Pharmaceutical Preparations (2834)	223542636

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1465822	Jeenarine Narine	C/O Epic Pharma, Llc 227-15 North Conduit Avenue Laurelton NY 11413		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-11-14	465,090	$0.12	16,133,379	No	4	S	Indirect	By Epic Investments, LLC
Common Stock	Disposition	2013-11-15	318,050	$0.12	16,063,408	No	4	S	Indirect	By Epic Investments, LLC
Common Stock	Disposition	2013-11-18	1,170,000	$0.12	15,806,008	No	4	S	Indirect	By Epic Investments, LLC
Common Stock	Disposition	2013-11-19	21,000	$0.12	15,801,388	No	4	S	Indirect	By Epic Investments, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Epic Investments, LLC
No	4	S	Indirect	By Epic Investments, LLC
No	4	S	Indirect	By Epic Investments, LLC
No	4	S	Indirect	By Epic Investments, LLC

Footnotes

Jeenarine Narine is an equity owner and executive officer of each of Epic Investments, LLC (EI)and Epic Pharma, LLC (EP), which is a 10% owner of the issuer, and also serves as a director of the issuer.
Represents the reporting person's pro-rata ownership of the issuer owned by EP. The reporting person disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.